JOURNAL OF ALLOYS AND COMPOUNDS
·
2022
·
IF 6.371
Yining Ma,Dandan Zhu,Huaijuan Zhou,Yue Tang,Chenchen Hu,Xinyu Meng,Xiaodong Jin,Tongxiang Xu,Xun Cao
Vanadium dioxide (VO 2 ) material has been deemed as a potential anode candidate for aqueous lithium-ion batteries. Among its diversified polymorphs, the latest discovered VO 2 (D) receives the fewest reports on its application in energy storage. Herein, we successfully utilized a template-free solvothermal method to prepare VO 2 (D) submicron-spherical hierarchical structures, constructed with colibacillus-like nanorods . The VO 2 (D) submicron-spheres were applied as an active anode material into the aqueous lithium-ion battery, which exhibited suitable working potential. Furthermore, VO 2 (D)-based full cell with LiMn 2 O 4 as the cathode demonstrated high discharge capacity, good rate capability, and excellent cycling stability. The structural evolution, valence states of the VO 2 (D) electrode, and impedance variation of the full cell during cycling were investigated. The work reveals the potential of VO 2 (D) as a novel anode material for aqueous lithium-ion batteries.
✓ 已验证
DOI
高影响因子
CHEMICAL ENGINEERING JOURNAL
·
2025
·
IF 13.2
Jialong Xu,Yiqing Chen,Shaoan Zhang,Hongqiang Zhu,Ziqing Mao,Ziyi Lin,Zhishan Chen,Huiwang Lian,Ling Gao,Yang Li
Phospholipase D (PLD) activity plays a critical role in tumor progression, yet its highly sensitive detection remains challenging. In this study, we developed metal halide perovskite nanoprobes via a dual-anchoring strategy that employed co-encapsulation of phospholipid and cholesteryl hemisuccinate (Chs) for the sensitive and selective monitoring of PLD activity. The Chs molecule not only enhances the stability of the phospholipid membrane via its cholesterol moiety but also passivates surface defects of the perovskite through the succinate group, endowing the nanoprobes with exceptional optical properties (PLQY >90 %) and long-term aqueous stability (> 7 days). The nanoprobe operates via a turn-off fluorescence response triggered by PLD-specific hydrolysis of the phospholipid layer, achieving a low detection limit of 0.51 U/L and a wide linear range (5–2000 U/L) with good anti-interference capability. Furthermore, the nanoprobes were successfully applied to in situ imaging of PLD activity in living cells, enabling discrimination between tumor cells with different PLD expression levels. This study not only paves the way for designing novel perovskite-based probes for biomedical applications but also offers a valuable fluorescent imaging tool to monitor tumor progression.
✓ 已验证
产品关联
DOI
高影响因子
ANALYTICA CHIMICA ACTA
·
2026
·
IF 6.1
Congcong Jia,Min Zhu,Yingtung Lo,Meixiang Yu,Xinyi Xia,Weiwei Ji,Xiang Cao,Yakun Wan,Jianzhong Lu,Hai Zhang
Background Early screening for venous thromboembolism and the precise use of anticoagulant drugs are crucial, and further basic innovations are urgently needed to advance related diagnostic and therapeutic practices. This study aimed to develop an innovative antibody for detecting D-dimer and to verify its performance. The core aim was to screen a pair of variable domains of the heavy chain of heavy-chain antibodies (VHH) that can specifically recognize unique epitopes on the D-dimer molecule. This study is expected to promote technological advancements in the diagnosis, risk assessment, and efficacy monitoring of thrombotic diseases. Results D-dimer-positive clones underwent positive and negative screening across seven rounds of phage biopanning, yielding a pair of VHHs. The superior thermal stability of the sandwich VHH pair was demonstrated after continuous heating at 80 °C for up to 1 h by comparison with a commercial monoclonal antibody. Subsequently, by integrating the reliable and convenient Luminex platform with these novel VHHs, a new detection method for D-dimer was established under optimal conditions, with a wide quantitative range of 0.5 to 1000 ng/mL and detection limit as low as 0.25 ng/mL. The recovery rate of spiked samples ranged from 99.3% to 106.0%, with a relative standard deviation of 1.1% to 3.2%. Furthermore, this newly developed VHH-based Luminex assay was utilized to examine clinical D-dimer samples, and its performance was evaluated by correlation analysis with the clinical INNOVANCE® D-Dimer Assay, resulting in a Pearson correlation coefficient of 0.99086 (P < 0.0001). Significance This study identified a novel VHH pair targeting D-dimer, demonstrating good binding activity and exceptional thermal stability, making it highly effective for bioanalysis experiments. Utilizing the reliable and efficient Luminex platform, a detection method for D-dimer was developed, exhibiting substantial potential for applications in venous thrombus screening, anticoagulant efficacy assessment, and related fundamental research.
✓ 已验证
DOI
PubMed
高影响因子
APPLIED SURFACE SCIENCE
·
2025
·
IF 6.9
Guanhua Zhang,Mingwang Lu,Qitong Sheng,Guangjian Xing,Xiaojing Yang,Xiaofei Yu,Xinghua Zhang,Zunming Lu,Lanlan Li
The development of highly efficient and stable bifunctional electrocatalysts capable of simultaneously catalyzing the oxygen reduction reaction (ORR) and the oxygen evolution reaction (OER) is critical for advancing zinc-air batteries (ZABs). However, the linear scaling relationship (LSR) governing the adsorption energies of oxygen species imposes constraints on the concurrent enhancement of ORR and OER performance. In this study, we report the synthesis of a novel FeSn/NC catalyst that exhibits strong p-d orbital hybridization by incorporating p-block Sn metal into d-block Fe metal. This strategy facilitates the manipulation of the d-band center and enables the effective formation of low-spin (LS) Fe 3+ simultaneously. The regulation of the d-band center is identified as an effective strategy to enhance the adsorption energy of OOH* and OH* intermediates, while the LS Fe 3+ configuration can effectively weaken the adsorption strength of the O* intermediate. Consequently, this p-d hybridized Fe-based catalyst successfully overcomes the constraints imposed by LSR, thereby boosting bifunctional activity for both ORR and OER. The synthesized FeSn/NC catalyst demonstrates exceptional bifunctional performance with a potential difference (ΔE) of 0.65 V between ORR and OER activities. Furthermore, ZAB based on FeSn/NC achieves an impressive peak power density of 186.0 mW cm −2 , while maintaining stable operation over 700 h during cycling tests. This work offers new insights into designing high-performance bifunctional electrocatalysts through strategies involving synergistic modulation of d-band center and spin state.
✓ 已验证
产品关联
DOI
高影响因子
VIBRATIONAL SPECTROSCOPY
·
2022
·
IF 2.382
Zhiqiang Wang,Siqi Duan,Bin Fang,Zhenxiang Liu,Ruiting Zhang,Lin Ma,Ke Lin
Identifying the molecular structures of drugs are important for understanding the molecular interactions between drugs and proteins. Especially in situ measurement of drug structures that interact with proteins in aqueous solutions or cells is a challenge. In this work, mandelic acid (MA) was used as a model molecule to prove that the Raman spectra in the C-H or C-D stretching region can be employed to identify the molecular structure through theoretical and experimental Raman spectra and molecular dynamics simulations methods. Using the experimental and theoretical Raman spectra of MA rotamers, C α -H was determined to be trans (higher than 2950 cm −1 ) and nontrans (below 2950 cm −1 ) from the α-OH group for solid DL-MA (~2961 cm −1 ) and D -MA (~2898 cm −1 ), respectively, which agreed well with the results from X-ray diffraction. Molecular dynamic (MD) simulations and Raman band of the MA aqueous solution revealed that the C α -H group was determined to be nontrans from the α-OH group, the structure of the carboxyl group was cis (~2910 cm −1 ), the carboxyl group was roughly vertical to the C α -benzene bond, and the benzene ring was approximately coplanar with the C α -H bond. Our work also paves that the Raman spectra in the C-D or C-H stretching region could be used as fingerprint regions to study the structure of drugs.
✓ 已验证
产品关联
DOI
高影响因子
Journal of the Mechanical Behavior of Biomedical Materials
·
2023
·
IF 3.9
Wanzhen Li,Yongqi Yang,Jun Wang,Ting Ge,Shuixia Wan,Lin Gui,Yugui Tao,Ping Song,Liangjun Yang,Fei Ge,Weiwei Zhang
At present, simple anti-tumor drugs are ineffective at targeting bone tissue and are not purposed to treat patients with bone metastasis. In this study, zoledronic acid (ZOL) demonstrated excellent bone-targeting properties as a bone-targeting ligand. The metal-organic framework (MOF) known as ZIF-90 was modified with ZOL to construct a bone-targeting-based drug delivery system. Chlorin e6 (Ce6) was loaded in the bone-targeted drug delivery system and combined with 2-deoxy-D-glucose (2-DG), which successfully treated bone tumors when enhanced photodynamic therapy was applied. The Ce6@ZIF-PEG-ZOL (Ce6@ZPZ) nanoparticles were observed to have uniform morphology, a particle size of approximately 210 nm, and a potential of approximately −30.4 mV. The results of the bone-targeting experiments showed that Ce6@ZPZ exhibited a superior bone-targeted effect when compared to Ce6@ZIF-90-PEG. The Ce6@ZPZ solution was subjected to 660 nm irradiation and the resulting production of reactive oxygen species increased over time, which could be further increased when Ce6@ZPZ was used in combination with 2-DG. Their combination had a stronger inhibitory capacity against tumor cells than either 2-DG or Ce6@ZPZ alone, increasing the rate of tumor cell apoptosis. The apoptosis rate caused by HGC-27 was 61.56% when 2-DG was combined with Ce6@ZPZ. In vivo results also showed that Ce6@ZPZ combined with 2-DG maximally inhibited tumor growth and prolonged mice survival compared to the other experimental groups. Therefore, the combination of PDT and glycolytic inhibitors serves as a potential option for the treatment of cancer.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
POLYMER DEGRADATION AND STABILITY
·
2023
·
IF 5.9
Nouman Ali Shah,Rui Hong,Xue Yang,Shi-Shu Huang,Rizwan M. Gul,Yuwei Liu,Lingli Li,Jia-Zhuang Xu,Ka Li,Zhong-Ming Li
Maintaining reliability remains a great challenge for ultrahigh molecular weight polyethylene (UHMWPE) bearings due to oxidation in biological environments. This work aimed at inspecting the efficacy of the hybrid antioxidant strategy in stabilizing crosslinked UHMWPE under an in vitro clinically relevant accelerated aging condition. The hybrid antioxidant system was composed of vitamin E (VE) and D-sorbitol (DS) as primary and secondary antioxidants, respectively. The already established in vitro clinically relevant accelerated aging was performed via squalene absorption and subsequent thermal oxidation treatment. Compared to the use of VE alone, the combination of VE and DS significantly protracted the oxidation induction time of UHMWPE with no apparent oxidation after aging, showing a notable synergistic effect on the oxidative stability of UHMWPE. The crosslink density was higher for VE/DS/UHMWPE than VE/UHMWPE at each aging period. It revealed that the hybrid antioxidant strategy settled the longstanding contradiction between oxidation stability and crosslinking of UHMWPE. Attributed to improved oxidation stability, there was a positive reversal in the tensile property between VE/DS/UHMWPE and VE/UHMWPE after aging, where comparable ultimate tensile strength and higher elongation at break were observed. These findings underline the high potential of the hybrid antioxidant strategy for developing artificial joint materials with desired ability to resist oxidation and balanced performance.
✓ 已验证
产品关联
DOI
高影响因子
INTERNATIONAL IMMUNOPHARMACOLOGY
·
2017
·
IF 2.956
Ye Tian,Zheng Li,Bingyu Shen,Qiaoling Zhang,Haihua Feng
Morin , a bioactive flavonoid extracted from the bark of Moraceae plants and many medicinal herbs, has anti-inflammatory and antioxidative effects. In this research, we explored the protective effects of morin against lipopolysaccharide (LPS) and d -galactosamine (D-GalN) induced acute liver injury in mice. Mice were given an intraperitoneal injection of morin before LPS and D-GalN treatment and the HepG2 cells were only given morin to investigate its effects. The results showed that morin markedly inhibited the production of serum alanine transaminase (ALT), aspartate aminotransferase (AST), interleukin-6 (IL-6), tumor necrosis factor (TNF-α) and hepatic TNF-α, IL-6, and myeloperoxidase (MPO) induced by LPS/D-GalN. In order to evaluate morin effect in the future, we investigated the expression of nuclear factor E2 related factor 2 (Nrf2), nuclear factor-kappaB (NF-κB), toll like receptor 4 (TLR4) on liver injury. Taken together, these results suggested that morin could exert the anti-inflammatory and anti-oxidative effects against LPS/D-GalN-induced acute liver injury by activating Nrf2 signal pathways and inhibiting NF-κB activation.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
EUROPEAN JOURNAL OF PHARMACOLOGY
·
2024
·
IF 4.2
Yufang Ma,Zhenming Ma,Yiyuan Zhang,Chunyun Luo,Puxin Huang,Jing Tong,Hong Ding,Honghui Liu
Apigenin and baicalein are structurally related flavonoids that have been reported to have multiple pharmacological activities. The aim of this study was to investigate the protective effects and potential mechanisms of apigenin and baicalein in D-galactose-induced aging rats. First, apigenin and baicalein showed remarkable antioxidant activity and anti-glycation activity in vitro. Secondly, the protective effects of apigenin and baicalein on aging rats were investigated. We found that apigenin and baicalein supplementation significantly ameliorated aging-related changes such as declines in the spatial learning and memory and histopathological damage of the hippocampus and thoracic aorta. In addition, our data showed that apigenin and baicalein alleviated oxidative stress as illustrated by decreasing MDA level, increasing SOD activity and GSH level. Further data showed that they significantly reduced the accumulation of advanced glycation end products (AGEs), inhibited the expression of RAGE, down-regulated phosphorylated nuclear factor (p–NF–κB (p65)). Our results suggested that the protective effects of apigenin and baicalein on aging rats were at least partially related to the inhibition of AGEs/RAGE/NF-κB pathway and the improvement of oxidative damage. Overall, apigenin and baicalein showed almost equal anti-aging efficacy. Our results provided an experimental basis for the application of apigenin and baicalein to delay the aging process.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
JOURNAL OF COLLOID AND INTERFACE SCIENCE
·
2024
·
IF 9.4
Shan Xu,Dongxu Jiao,Xiaowen Ruan,Zhaoyong Jin,Yu Qiu,Jinchang Fan,Lei Zhang,Weitao Zheng,Xiaoqiang Cui
Efficient production of green hydrogen energy is crucial in addressing the energy crisis and environmental concerns. The oxygen evolution reaction (OER) poses a challenge in conventional overall water electrolysis due to its slow thermodynamically process. Urea oxidation reaction (UOR) offers an alternative anodic oxidation method that is highly efficient and cost-effective, with favorable thermodynamics and sustainability. Recently, there has been limited research on bifunctional catalysts that exhibit excellent activity for both OER and UOR reactions. In this study, we developed a selenium and iron co-doped nickel sulfide (SeFe-Ni 3 S 2 ) catalyst that demonstrated excellent Tafel slopes of 53.9 mV dec −1 and 16.4 mV dec −1 for OER and UOR, respectively. Density Functional Theory (DFT) calculations revealed that the introduction of metal (iron) and nonmetallic elements (selenium) was found to coordinate the d-band center, resulting in improved adsorption/desorption energies of the catalysts and reduced the overpotentials and limiting potentials for OER and UOR, respectively. This activity enhancement can be attributed to the altered electronic coordination structure after the introduction of selenium (Se) and iron (Fe), leading to an increase in the intrinsic activity of the catalyst. This work offers a new strategy for bifunctional catalysts for OER and UOR, presenting new possibilities for the future development of hydrogen production and novel energy conversion technologies. It contributes towards the urgent search for technologies that efficiently produce green hydrogen energy, providing potential solutions to mitigate the energy crisis and protect the environment.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
PHYTOMEDICINE
·
2025
·
IF 8.3
Yufeng Deng,Qi hu,Zhiying Song,Mengyuan Nie,Zhiguo Wu,Yongrong Lei,Meng Liu,Dujuan Zhan,Baogang Xie
Objective Hepatocellular carcinoma (HCC) remains a leading cause of cancer mortality. Targeted therapies like lenvatinib face limitations due to resistance and immunosuppression. d -Glucaro-1,4-lactone (1,4-GL), a bioactive natural compound with anti-HCC activity, holds unexplored synergistic potential with lenvatinib. This study investigates the combinatorial efficacy of 1,4-GL and lenvatinib against HCC and elucidates the underlying mechanisms. Methods Efficacy was evaluated in H22 tumor-bearing mice treated with lenvatinib (20 mg/kg/day) ± 1,4-GL (25, 50, 100 mg/kg/day). Tumor inhibition, serum cytokines (TNF-α, IFN-γ, AFP), oxidative stress markers (MDA, SOD), liver enzymes (ALT, AST), and splenic T-cell subsets (flow cytometry) were assessed. Histopathology was analyzed via H&E staining. Lenvatinib pharmacokinetics (serum, liver, tumor) with/without 1,4-GL was determined in mice and SD rats using UPLC-MS/MS. In vitro, combinatorial effects on proliferation (CCK-8), migration (scratch assay), and clonogenicity (colony formation) were tested in Huh7 and HepG2 cells. STAT3 phosphorylation and PD-L1 expression (protein: Western blot; mRNA: RT-qPCR) were analyzed. PD-L1 induction was achieved using IFN-γ (20 ng/ml). Results The medium-dose combination (LMGL) achieved 89.97% tumor inhibition in H22 mice, significantly reducing tumor mass by 75% vs. lenvatinib alone (0.21±0.18 g vs. 0.84±0.79 g, p < 0.01). H&E staining revealed extensive necrosis in combination groups. Serum TNF-α and IFN-γ levels significantly increased ( p < 0.001), while AFP approached baseline. Flow cytometry showed an elevated CD4⁺/CD8⁺ T-cell ratio. Oxidative stress was modulated (reduced MDA and elevated SOD, p < 0.01). Pharmacokinetic studies revealed no significant differences in lenvatinib exposure or steady-state concentrations ( p > 0.05) with 1,4-GL co-administration. In vitro, 1,4-GL significantly reduced lenvatinib's IC 50 (Huh7: 18.54 μmol/l; HepG2: 30.34 μmol/l). Combinatorial treatment markedly downregulated PD-L1 protein/mRNA and inhibited STAT3 phosphorylation ( p < 0.05). Scratch and colony formation assays indicated synergy stemmed from immunomodulation and signaling inhibition, not enhanced anti-migration/proliferation. Conclusion 1,4-GL potently synergizes with lenvatinib against HCC by enhancing oxidative stress, reconstituting antitumor immunity, and suppressing the STAT3/PD-L1 signaling axis, without perturbing lenvatinib pharmacokinetics. This defines a novel phytochemical-based combinatorial strategy with significant clinical translation potential for HCC therapy.
✓ 已验证
产品关联
DOI
PubMed
高影响因子
Nano Today
·
2025
·
IF 10.9
Wei Hu,Jiaxi Xu,Mingchen Lv,Min Sun,Zhen Fan,Jianzhong Du
Immunotherapy offers enduring cancer treatment by activating the immune system to eliminate cancer cells, but faces challenges like tumor immune evasion and low immunogenicity. Chirality, crucial in biological interactions, remains underexplored for immune modulation. Inspired by the metal-binding domain of manganese superoxide dismutase, we develop a cyclic D/L peptide for chirality-driven immune activation. The cyclic L -Tyr- D -His- L -Asp- D -His (YhDh) peptide coordinates with Mn 2+ to self-assemble into nanoparticles, cloak with tumor cell membranes for homologous targeting. Compared to all-L or all-D peptides, YhDh nanoparticles promote costimulatory molecule expression on dendritic cells (DCs). Upon intravenous administration, they are oxidized at melanoma sites with tyrosinase overexpression, enabling photothermal-induced immunogenic cell death (ICD). Chiral peptides synergize with Mn 2+ -mediated cGAS-STING activation and ICD, enhancing DC maturation and T cell infiltration (4.36- and 2.88-fold), suppressing tumor metastasis while establishing immune memory. Such chiral cyclic peptides offer a novel strategy for immune activation by regulating peptide chirality.
✓ 已验证
产品关联
DOI
高影响因子
危险品化学品经营许可证（带存储）